Research update – ProQR
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Search
Search results
ReNeuron trial FAQs
You may have heard that a cell-based treatment approach (sometimes referred to as a “stem cell treatment”), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.
The Big Give Christmas Challenge 2022
Last year, with your help, we raised an incredible £53,752, which made great strides in helping our medical research recover from the pandemic.
A new approach to treating inherited sight loss
A new approach to treating inherited sight loss
e-Newsletter September 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK.
e-Newsletter May 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Walking into Wellness: Uniting Movement and Mental Health this May!
Did you know May is National Walking Month? As part of Mental Health Awareness Week, we're exploring the power of movement.